28-Sep-2025 Cutting country dementia risks through community collaboration University of South Australia Dementia is the leading cause of death in Australia. Yet despite its prevalence, little is known about whether rural and regional Australians are more likely to develop the condition than their city counterparts.
27-Sep-2025 Early screening saves children from premature heart disease | World Heart Day BGI Genomics Inherited heart conditions place millions of children at risk from birth. Up to 80% of premature cardiovascular deaths are preventable with early screening and healthier lifestyle options, according to the World Heart Federation. Without early detection, conditions such as congenital heart defects and familial hypercholesterolemia (FH) can quietly disrupt growth, energy levels, and long-term organ function. Whole Genome Sequencing (WGS) can detect these risks at the earliest possible stage. It shifts cardiac care away from crisis management toward proactive, precision prevention.
27-Sep-2025 Later-in-life pregnancies detection reduces risk of chromosomal abnormalities BGI Genomics Later pregnancies carry higher risks. Advances in genetic reproductive medicine, like IVF and NIPT are making it possible for women to experience healthy pregnancies. With the support of genetic technologies, they can now deliver healthy babies at ages once considered beyond the reproductive window.
26-Sep-2025 What research really says about autism University of Utah Health While research is ongoing to better understand autism, decades of work have established solid evidence about what causes autism and how to best support autistic people.
26-Sep-2025 Early psoriasis treatment leads to long-term relapse freedom, study finds BGI Genomics Psoriasis is a serious, incurable systemic disease that causes painful skin lesions and significantly increases the risk of cardiovascular disease, diabetes, and arthritis. It affects about 125 million people worldwide—roughly 2–3% of us—and too often demands lifelong treatment. New research published in Nature shows that early treatment, within one year of disease onset, can significantly reduce the risk of relapse. Genetic profiling can support clinicians on precise diagnosis and timely treatment. Moving from one-size-fits-all care to durable and personalized healthcare.
26-Sep-2025 New ORNL aluminum alloy to strengthen domestic auto supply chain DOE/Oak Ridge National Laboratory Over the next decade, aluminum auto body scrap will flood salvage systems, much of it too impure for reuse in critical parts. ORNL researchers developed RidgeAlloy, a new aluminum alloy that turns low-value scrap into a reliable, high-value domestic supply for structural automotive manufacturing. Funder DOE/US Department of Energy
26-Sep-2025 E-bike rebates boost affordability, health and sustainable mobility University of British Columbia New UBC study finds B.C.’s income-based e-bike rebate program improved access, encouraged active travel and reduced car use.
26-Sep-2025 UBC launches world’s first mushroom-powered waterless toilet University of British Columbia UBC researchers are launching the world’s first mushroom-powered waterless toilet at the UBC Botanical Garden on Sept. 26. The MycoToilet turns human waste into nutrient-rich compost and features a modern, sustainable design.
26-Sep-2025 Global Forum on Mechanical Engineering 2025 to spotlight the future of humanoid AI and robotics National Research Council of Science & Technology The Korea Institute of Machinery and Materials (KIMM, President Seog-Hyeon Ryu), under the National Research Council of Science & Technology (NST), hosted the 2025 Global Forum on Mechanical Engineering on September 26 (Friday) at the National Assembly Library Auditorium in Seoul. The forum was co-organized with National Assembly members Seung-Rae Cho and Jung-A Hwang of the Democratic Party of Korea, and Hyung-Doo Choi and Chung-Kwon Park of the People Power Party. This year marked the 12th annual forum, under the theme “The Future of Humanoid AI and Robotics.” Funder Ministry of Science and ICT
25-Sep-2025 Genetic screening could cut 33% of global cardiovascular deaths BGI Genomics Cardiovascular diseases (CVD) cause about one in three deaths worldwide. The World Health Organization (WHO) estimates 19.8 million CVD deaths in 2022, roughly 32% of all deaths. Care remains reactive and generic. AI-powered integration of multi-omics and genomic data improves risk prediction and speeds diagnosis beyond traditional tools, study shows. With the support of advanced genetic technology, clinician can choose the right therapy to the right person, thus easing the burden on patients and health systems.
